Drug Prices
Study brings personalised immunotherapy prescriptions closer
Research showed that prescribing based solely on levels of proteins present is unlikely…
Drug Prices
Drug Prices
Drug Prices
Medicines for Malaria Venture and Novartis move to phase 3 trial
Ganaplacide/lumefantrinein new study as world faces emerging resistance to malaria treatments Novartis and…
Drug Prices
Takeda findings may minimise haemophilia treatment side effects
Research from Takeda and Institute Krems Bioanalytics of IMC Krems and will help…
Drug Prices
Turbine boosts AI platform to deliver cancer treatments
€20m financing will focus on treatment pathways, new partnerships and team expansion Turbine,…
Drug Prices
Infex begins study of pseudomonas aeruginosa candidate RESP-X
Phase 1 research will evaluate tolerability and safety of therapy among healthy volunteers…
Drug Prices
Iveric Bio receives new therapy designation for avacincaptad pegol
FDA grants status following primary endpoint data from pivotal trials treating geographic atrophy…
Drug Prices
NICE recommends Sobi’s Doptelet to treat thrombocytopenia
Primary ITP is a rare autoimmune condition characterised by high platelet destruction Sobi…
Drug Prices
Kidney Cancer UK receives commission from NICE
The charity commissioned a two-year service quality audit of over 18,000 kidney cancer…
Drug Prices
Association of the British Pharmaceutical Industry lays down new antibiotics mission
The challenge of resistant infections will require new antibiotics according to the ABPI…
Drug Prices
NICE recommends Pfizer’s Paxlovid on NHS
Therapy will be available on the NHS as a clinical treatment option for…
